Cigna's strategic position has improved through Medicare Advantage exit and Humana stake monetization, leaving the company more focused on commercial insurance and Evernorth services. Express Scripts PBM is the key earnings driver and faces the same regulatory scrutiny as peers. Specialty pharmacy growth durable. Capital allocation focused on Evernorth services growth. Less direct exposure to medical cost trend than Aetna/United.
Thesis reviewed May 29, 2026
The Cigna Group is headquartered in United States, which is currently showing elevated risk signals.
🇺🇸United States82EXITView United States risk detail →🏥Healthcare33NEUTRAL| Ticker | Company | Score | Gap | Signal Δ | Action |
|---|---|---|---|---|---|
| CVS | CVS Health Corporation | 40 | +15% | ↓3% | AVOID |
| HCA | HCA Healthcare Inc. | 40 | +9% | ↓3% | EARLY |
| UNH | UnitedHealth Group Inc. | 37 | +16% | ↓3% | AVOID |
| TMO | Thermo Fisher Scientific Inc. | 37 | +11% | ↓3% | EARLY |
| CI | The Cigna Group | 37 | +9% | ↓3% | NEUTRAL |
| ELV | Elevance Health Inc. | 37 | +7% | ↓3% | NEUTRAL |
| TEVA | Teva Pharmaceutical Industries Ltd. | 37 | +9% | ↓3% | NEUTRAL |
Investors who hold CI may also have indirect exposure through these country funds.
Cigna fully exits Medicare Advantage, focused on commercial
Evernorth specialty pharmacy revenue growth +18%
Estimates · Yahoo Finance · Not audited figures
[Senate Hearing 119-68] [From the U.S. Government Publishing Office] S. Hrg. 119-68 Senate Hearings Before the Committee on Appropriations _______________________________________________________________________ Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations …
[Senate Hearing 119-360] [From the U.S. Government Publishing Office] S. Hrg. 119-360 THE DOCTOR IS OUT: HOW WASHINGTON'S RULES DROVE PHYSICIANS OUT OF MEDICINE ======================================================================= HEARING BEFORE THE SPECIAL COMMITTEE ON AGING …
[House Hearing, 119 Congress] [From the U.S. Government Publishing Office] EVALUATING THE FINANCIAL CRIMES ENFORCEMENT NETWORK ======================================================================= HEARING BEFORE THE SUBCOMMITTEE ON NATIONAL SECURITY, ILLICIT FINANCE, AND INTERNATIONAL FINANCIAL INSTITUTIONS …
| Politician | Party | Type | Amount | Trade Date | Return |
|---|---|---|---|---|---|
| Julie JohnsonTX | Buy | $1k–$15k | Sep 23, 25 | ||
| Alan Armstrong | Buy | $1k–$15k | Mar 27, 26 | ||
| Jared MoskowitzFL | D | Buy | $1k–$15k | Mar 23, 26 | -4.5% |
| Gilbert CisnerosCA | D | Buy | $1k–$15k | Mar 13, 26 | +1.1% |
| Julie JohnsonTX | D | Buy | $1k–$15k | Dec 18, 25 | +0.4% |
| Julia LetlowLA | R | Buy | $1k–$15k | Oct 23, 24 | +2.6% |
| Julia LetlowLA | R | Buy | $1k–$15k | Apr 22, 25 | +2.6% |
| Gilbert CisnerosCA | D | Buy | $1k–$15k | Dec 19, 25 | +1.1% |